This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (50)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Vincent Vinciguerra, MD; Morton Coleman, MD; Charles I. Jarowski, MD; Thomas J. Degnan, MD; Richard T. Silver, MD

JAMA. 1977;237(1):33-35.

Abstract
A new four-drug combination chemotherapeutic regimen (BVDS) was used in the treatment of advanced Hodgkin disease resistant to MOPP (mechlorethamine hydrochloride, vincristine sulfate, procarbazine hydrochloride, and prednisone). The BVDS regimen, consisting of 12 cycles of bleomycin sulfate, vinblastine sulfate, doxorubicin hydrochloride (Adriamycin), and streptozocin (streptozotocin), was administered to ten patients. Responses were seen in five (50%) of these patients. Complete remissions occurred in three (30%). These results suggest that BVDS is an effective alternative regimen to MOPP, and may be of benefit not only to patients resistant to MOPP, but also to newly-diagnosed patients with advanced Hodgkin disease when combined sequentially with MOPP.

(JAMA 237:33-35, 1977)

Author Affiliations
From the Divisions of Hematology-Oncology, Department of Medicine, Cornell University Medical College, North Shore University Hospital (Drs Vinciguerra and Degnan) and The New York Hospital (Drs Coleman, Jarowski, and Silver), New York.

Footnotes
Reprint requests to Division of Hematology-Oncology, The New York Hospital-Cornell Medical Center, 525 E 68th St, New York, NY 10020 (Dr Coleman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Combination Chemotherapy for Advanced Hodgkin's Disease After Failure of MOPP: ABVD and B-CAVe
HARKER et al.
ANN INTERN MED 1984;101:440-446.
ABSTRACT  

Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease
SANTORO et al.
ANN INTERN MED 1982;96:139-143.
ABSTRACT  

The Cure of Disseminated Hodgkin's Disease: Prospects and Problems
STREULI and ULTMANN
ANN INTERN MED 1980;92:693-695.
ABSTRACT  

Combination Chemotherapy With Doxorubicin and Lomustine: Treatment of Refractory Hodgkin's Disease
Williams and Einhorn
JAMA 1977;238:1659-1661.
ABSTRACT